Calamos Wealth Management LLC Cuts Stake in Boston Scientific Corporation $BSX

robot
Abstract generation in progress

Calamos Wealth Management LLC decreased its stake in Boston Scientific Corporation by 24.4% in the fourth quarter, reducing its holdings to 117,214 shares valued at $11.176 million. Other institutional investors showed mixed activity, with some increasing and others initiating positions. The article also details recent insider selling by CEO Michael F. Mahoney and provides a summary of mixed analyst ratings and key news impacting Boston Scientific’s stock performance and outlook for 2026.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin